Subjects: VACINAÇÃO (IMUNOLOGIA), CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTORA, G. D. et al. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006, Anais.. Paris: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 01 nov. 2024.APA
Victora, G. D., Socorro-Silva, A., Volsi, E., Abdallah, K., Lima, F. D., Michaluart Junior, P., et al. (2006). Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. In . Paris: Faculdade de Medicina, Universidade de São Paulo.NLM
Victora GD, Socorro-Silva A, Volsi E, Abdallah K, Lima FD, Michaluart Junior P, Rodrigues Junior JM, Lima KM, Silva CL, Kalil Filho J, Coelho V. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006 ;[citado 2024 nov. 01 ]Vancouver
Victora GD, Socorro-Silva A, Volsi E, Abdallah K, Lima FD, Michaluart Junior P, Rodrigues Junior JM, Lima KM, Silva CL, Kalil Filho J, Coelho V. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006 ;[citado 2024 nov. 01 ]
